The Food and Drug Administration has approved the first so-called biosimilar drug for use in the United States. The New York Times reports.» Read More
Unilife Chairman & CEO Alan Shortall, discusses partnerships with major pharma and biotech firms to deliver more advanced drugs in syringes and pumps.
M&A experts forecast there will be more major pharma deals in 2015 — but the U.K. won’t be a focus and the deals won’t be done for tax reasons.
The Ice Bucket Challenge raised $115 million for the ALS Association last summer. A look at how those donations were used.
Price cuts, which may hurt pharmaceutical margins, are fundamentally better for consumers, said Dr. Steve Miller of Express Scripts.
CNBC's Meg Tirrell reports where the money raised in the ALS ice bucket challenge went.
Outbreaks of measles and whooping cough in California have rekindled debates over "anti-vaxxers"——here is a map of where they live.
Pfizer is buying Hospira, which calls itself the world's leading provider of injectable drugs and infusion technologies. So what the heck are they?
AstraZeneca reported a loss for the fourth quarter of 2014, but stressed that it was on track to return to growth by 2017.
Yaron Werber, Citigroup, shares his basket approach to investing in biotech stocks Gilead, Celgene and others.
Discounts on Gilead's hepatitis C drugs this year will be 46 percent, way more than investors and analysts expected.
Gilead Sciences posted strong sales of its hepatitis C drugs Harvoni and Sovaldi, sending its net profit up more than four-fold for the quarter.
Shares of GlaxoSmithKline jumped on Wednesday, despite the company posting a 3 percent fall in full-year revenue.
Merck said the U.S. FDA intends to rescind its "breakthrough" designation for its experimental combination treatment for hep C.
Sen. Rand Paul clarified his views on vaccinations following an interview with CNBC in which he linked childhood vaccines with disorders.
A leading group of physicians is warning that high prices of specialty drugs is creating barriers to care for patients.
Public health officials implored parents to vaccinate their children against the measles in a Tuesday Congressional hearing.
Dr. Gail Shust, an infectious disease specialist, tells CNBC, "It really is not just a personal choice but a public health issue."
Sanofi launched an inhalable insulin in the U.S. in a potential boost for its flagging diabetes drug sales and for patient quality of life.
A trial of an Ebola drug has been halted because of a sharp decline in patients with the disease in Liberia, the NYT reports.
CNBC's Meg Tirrell, has the latest details on the White House summit with medical researchers.
Get the best of CNBC in your inbox